Aimee D. Kohn

7.7k citations
29 papers · 6.5k · 3 hit papers · h-index 20

Impact in

    • Wnt/β-catenin signaling in development and cancer
    • PI3K/AKT/mTOR signaling in cancer
    • Metabolism, Diabetes, and Cancer
    • Cancer-related gene regulation
    • Protein Kinase Regulation and GTPase Signaling
    • Pluripotent Stem Cells Research
    • Congenital heart defects research

Papers in

    • Cancer-related gene regulation 6
    • Wnt/β-catenin signaling in development and cancer 6
    • PI3K/AKT/mTOR signaling in cancer 5
    • Protein Kinase Regulation and GTPase Signaling 5
    • Signaling Pathways in Disease 2
    • Growth Hormone and Insulin-like Growth Factors 2

Aimee D. Kohn

28 papers receiving 6.4k citations

Aimee D. Kohn's Hit Papers

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial 2017 · 461 citations
4610+10+20Years since publication50010001.5k

Peers

Aimee D. Kohn
Comparison fields: 5 of 111
  • Molecular Biology 4.8k
  • Cancer Research 544
  • Cell Biology 636
  • Oncology 897
  • Genetics 232
Replace Tung O. Chan with:
Tung O. Chan United States
Roshantha A.S. Chandraratna United States
Derek P. Brazil United Kingdom
Peter D. Cron Switzerland
Takaya Satoh Japan
Ainara Egia United States
Christina N. Bennett United States
Juha Saharinen Finland
Andrew J. Paterson United States
Yasuko Kureishi Japan
Aimee D. Kohn relative to Tung O. Chan United States Tung O. Chan's profile →
Citations per field
00.5×2×2.9×
Tung O. Chan · 1×
Citations per year

Countries citing papers authored by Aimee D. Kohn

Since Specialization
Citations

This map shows the geographic impact of Aimee D. Kohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimee D. Kohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimee D. Kohn more than expected).

Fields of papers citing papers by Aimee D. Kohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimee D. Kohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimee D. Kohn. The network helps show where Aimee D. Kohn may publish in the future.

Co-authors

The 25 scholars most cited alongside Aimee D. Kohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aimee D. Kohn Line = papers co-authored together Aimee D. Kohn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1
WNT and β-catenin signalling: diseases and therapies
Hit paper breakdown →
20041562
2
Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 Translocation
Hit paper breakdown →
19961098
3 2005619
4 2007498
5
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2017461
6 1996420
7 1998415
8 1995316
9 1998277
10 1999184
11 2007145
12 199874
13 200769
14
Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB.
200064
15 200960
16 200155
17 202342
18 200737
19 199734
20 198928

About Aimee D. Kohn

Aimee D. Kohn is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology, Immunology and Cancer Research, having authored 29 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer-related gene regulation (6 papers), Wnt/β-catenin signaling in development and cancer (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Pancreatic function and diabetes (3 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Molecular Biology (4.8k citations), Cancer Research (544 citations), Cell Biology (636 citations), Oncology (897 citations) and Genetics (232 citations). Aimee D. Kohn has collaborated with scholars based in United States, Italy and South Korea. Frequent co-authors include Randall T. Moon, Richard A. Roth, Ajamete Kaykas, Giancarlo V De Ferrari, Morris J. Birnbaum, Scott A. Summers, Kristina S. Kovacina, Pamela Scott, John C. Lawrence and Gregory J. Brunn. Their work appears in journals such as Journal of Biological Chemistry, Transplantation and Cellular Therapy, Endocrinology, Thyroid and Molecular Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact